Description
Demographic and baseline clinical characteristics of IBS trial participants are tabulated. Age, sex distribution, IBS subtype, and symptom duration are balanced between probiotic and placebo arms.
Figure 16
Source Paper
Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.Cite This Figure
![Figure 16: Demographic and baseline clinical characteristics of IBS trial participants are tabulated. Age, sex distribution, IBS subtype, and symptom duration are balanced between probiotic and placebo arms.]() > Source: Konstantinos Leventogiannis et al. "Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritabl." *Probiotics and antimicrobial proteins*, 2019. PMID: [29508268](https://pubmed.ncbi.nlm.nih.gov/29508268/)
<figure> <img src="" alt="Demographic and baseline clinical characteristics of IBS trial participants are tabulated. Age, sex distribution, IBS subtype, and symptom duration are balanced between probiotic and placebo arms." /> <figcaption>Figure 16. Demographic and baseline clinical characteristics of IBS trial participants are tabulated. Age, sex distribution, IBS subtype, and symptom duration are balanced between probiotic and placebo arms.<br> Source: Konstantinos Leventogiannis et al. "Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritabl." <em>Probiotics and antimicrobial proteins</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29508268/">29508268</a></figcaption> </figure>
Related Evidence
B
Lactobacillus plantarum for Irritable Bowel Syndrome (IBS)
B
Grade B · 5 studies
Bifidobacterium lactis for Chronic Constipation
B
Grade B · 4 studies
Lactobacillus acidophilus for Irritable Bowel Syndrome (IBS)
B
Grade B · 3 studies
Saccharomyces boulardii for Traveler's Diarrhea
Grade B · 4 studies